Income Taxes - Additional Information (Detail) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
|
Aug. 29, 2026
USD ($)
|
Aug. 30, 2025
USD ($)
|
Aug. 31, 2024
USD ($)
|
|
| Income Taxes | |||
| Additional excess tax benefits from stock option exercises compared to prior year | $ 30,700 | $ 58,200 | $ 81,400 |
| Future taxable income | 377,700 | 338,600 | |
| Deferred tax assets from net operating loss carryforwards | $ 50,500 | 33,200 | |
| Expiration date of NOLs start year | 2027 | ||
| Expiration date of NOLs end year | 2045 | ||
| Deferred tax assets for income tax credit carryforwards | $ 31,500 | 135,100 | |
| Expiration date of tax credit carryforwards start year | 2027 | ||
| Expiration date of tax credit carryforwards end year | 2052 | ||
| Valuation allowances on deferred tax assets | $ 21,762 | 11,331 | |
| Outside basis differences in foreign subsidiaries investments | $ 389,600 | ||
| New global minimum tax rate | 15 | ||
| Unrecognized tax benefits, if recognized would reduce effective tax rate, amount | $ 14,300 | 17,500 | |
| Deferred tax assets operating loss carryforwards and tax credits | 2,200 | 4,300 | |
| Accrued for payment of interest and penalties associated with unrecognized tax benefits | $ 900 | $ 3,800 | |
| Income tax examination, Description | The Company files U.S. federal, U.S. state and local, and international income tax returns. The Company is currently under examination by the IRS for fiscal years 2021 and 2024. With few exceptions, the Company is no longer subject to U.S. federal, U.S. state and local, or Non-U.S. examinations by tax authorities for fiscal year 2020 and prior. While the Company believes that it is adequately accrued for possible audit adjustments, the final resolution of these examinations cannot be determined at this time and could result in final settlements that differ from current estimates. | ||
| Tax Jurisdiction of Domicile [Extensible Enumeration] | UNITED STATES | ||
| Income Tax Examination, Year under Examination | 2021 2024 | ||